Cadralazine: Difference between revisions
Jump to navigation
Jump to search
Matt Pijoan (talk | contribs) m (Protected "Cadralazine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| Line 26: | Line 26: | ||
{{CMG}} | {{CMG}} | ||
'''Cadralazine''' is an [[antihypertensive]]. | '''Cadralazine''' is an [[antihypertensive]]. | ||
Revision as of 23:21, 8 August 2012
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C12H21N5O3 |
| Molar mass | 283.32684 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Cadralazine is an antihypertensive.
Categories:
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs